Delcath Systems to Participate at Upcoming Virtual Investor Conferences
08. März 2021 09:00 ET
|
Delcath Systems, Inc.
NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems to Participate at Upcoming Virtual Investor Conferences
11. Februar 2021 09:00 ET
|
Delcath Systems, Inc.
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems to Present at the H.C. Wainwright Virtual BioConnect Conference
11. Januar 2021 10:56 ET
|
Delcath Systems, Inc.
NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH ), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Announces Completion of Underwritten Public Offering
11. Dezember 2020 10:31 ET
|
Delcath Systems, Inc.
NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Announces Pricing of Public Offering of Common Stock
09. Dezember 2020 08:00 ET
|
Delcath Systems, Inc.
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Announces Proposed Public Offering of Common Stock
08. Dezember 2020 16:01 ET
|
Delcath Systems, Inc.
NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Kevin Muir Joins Delcath Systems, Inc. as VP, Commercial Operations
07. Dezember 2020 07:30 ET
|
Delcath Systems, Inc.
NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today...
Delcath Systems, Inc. Announces Third Quarter 2020 Results
11. November 2020 08:00 ET
|
Delcath Systems, Inc.
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today...
Delcath Systems, Inc. to Participate in Oppenheimer Fall MedTech Summit on Thursday, November 12, 2020
02. November 2020 16:01 ET
|
Delcath Systems, Inc.
NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on liver-directed treatment of primary and metastatic cancers, today...
Delcath Schedules Conference Call to Report 2020 Third Quarter Financial Results
02. November 2020 09:00 ET
|
Delcath Systems, Inc.
NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on liver-directed treatment of primary and metastatic cancers, today...